CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Monday reported a loss of $62.1 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of 75 cents per share.

The results surpassed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 76 cents per share.

The genome editing company posted revenue of $61,000 in the period, which did not meet Street forecasts. Seven analysts surveyed by Zacks expected $7 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT